Product Information
LITHIUM CARBONATE 150 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0873 per EA under NDC 62332001331. Its NADAC has been published 420 times since Jun 13, 2018.
Strength
150 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001331
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA079159On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE 150 MG CAP has been published 420 times since Jun 13, 2018, and over the history we have for it it has risen 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0873 per EA |
|---|---|
| All-time high | $0.1032 (Jan 10, 2024) |
| All-time low | $0.0626 (Dec 22, 2021) |
| 52-week high | $0.0896 |
| 52-week low | $0.0847 |
| Median price | $0.0809 |
| Average price | $0.0825 |
| Largest weekly change | +25.9% (Aug 21, 2024) |
| Weeks tracked | 420 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the LITHIUM CARBONATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 150 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.0873 per EA (NDC 62332001331), effective Jun 24, 2026.
How has the price of LITHIUM CARBONATE 150 MG CAP changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE 150 MG CAP has risen 7.1%. It has been tracked across 420 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 150 MG CAP?
Since Jun 13, 2018, the NADAC for LITHIUM CARBONATE 150 MG CAP has ranged from a low of $0.0626 (Dec 22, 2021) to a high of $0.1032 (Jan 10, 2024), with a median of $0.0809 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE 150 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LITHIUM CARBONATE 150 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures LITHIUM CARBONATE 150 MG CAP?
LITHIUM CARBONATE 150 MG CAP (NDC 62332001331) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification